Abstract
Bleomycin has been used extensively in the chemotherapy and radiodiagnosis of cancer (1). One of the most important aspects of its chemistry is its ability to coordinate a variety of metals. Recently, bleomycin-metal complexes have attracted particular attention because of their interesting behavior: (i) the copper(II) complex is a metabolic form of bleomycin (2), (ii) γ-emitting metal complexes such as 57CO, 99mTc, and 111In have been investigated as a means of visualizing tumors(3), and (iii) an oxygen-labile iron(II) complex may play an important role in DNA degradation by bleomycin(4,5). Sausville et al. reported that the conversion of SV40 DNA to acid-soluble products occurs at approximately equimolar levels of Fe(II), bleomycin, and DNA(4). Takita et al. have proposed that an oxygen activated by the bleomycin-Fe(II) complex is involved in the action of bleomycin on DNA(5). Additionally, it has been suggested that superoxide radical is one of the chemical mediators responsible for the enhancement of DNA chain breakage by bleomycin (6). Herein, the 1:1 bleomycin A2-Co(II) complex and its oxygen adduct complexes have been characterized by electron spin resonance (ESR) spectroscopy; the present results should serve to facilitate an understanding of the degradation of DNA by the bleomycinFe(II)-02 complex.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
H. Umezawa, Fed. Proc., 33, 2296 (1974).
M. Kanao, S. Tomita, S. Ishihara, A. Murakami, and H. Okada, Chemotherapy (Tokyo), 21, 1305 (1973).
J.J. Rasker, M.A.P.C. Poll, H. Beekhuis, M.G. Woldring, and H.O. Nieweg, J. Nucl. Med., 16, 1058 (1975).
E.A. Sausville, J. Peisach, and S.B. Horwitz, Biochem. Biophys. Res. Commun., 73, 814 (1976).
T. Takita, Y. Muraoka, T. Nakatani, A. Fujii, Y. Iitaka, and H. Umezawa, J. Antibiot. (Tokyo), 31, 1073 (1978).
R. Ishida and T. Takahashi,Biochem. Biophys. Res. Commun., 166, 1432 (1975).
A.D. Nunn, Int. J. Nucl. Med. Biol., 4, 216 (1977).
B.M. Hoffman D.L. Diemente and F. Basolo J. Am. Chern. Soc. 92, 61 (1970).
T. Yonetani, H. Yamamoto, and T. Iizuka, J. Biol. Chem.,249, 2169(1974).
M-Y.R. Wang, B.M. Hoffman, and P.F. Hollenberg, J. Biol. Chem., 252, 6268 (1977).
D. Diemente, B.M. Hoffman, and F. Basolo, J. Chem. Soc. Chem. Commun., 467 (1970).
E.W. Abel, J. Chem. Soc. Chem. Commun., 449 (1971).
T. Yonetani, H. Yamamoto, J.E. Erman, J.S. Leigh, and G.H. Reed, J. Biol. Chem., 247, 2447 (1972).
Y. Sugiura and K. Ishiza, J.Inorg. Biochem., in press.
Y. Sugiura, K. Ishiza, and K. Miyoshi, J. Antibiot. (Tokyo), 32, 453 (1979).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1979 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Sugiura, Y. (1979). Electron Spin Resonance Studies of 1:1:1 Bleomycin-Cobalt(II)-Qxygen Adduct Complex. In: Hect, S.M. (eds) Bleomycin: Chemical, Biochemical, and Biological Aspects. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-6191-9_12
Download citation
DOI: https://doi.org/10.1007/978-1-4612-6191-9_12
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-6193-3
Online ISBN: 978-1-4612-6191-9
eBook Packages: Springer Book Archive